Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 정효성filedCritical정효성
Priority to KR1019940020091ApriorityCriticalpatent/KR960006936A/en
Publication of KR960006936ApublicationCriticalpatent/KR960006936A/en
본 발명은 바이러스의 침투로 손상된 세포핵 단백질을 분해하는 단백질 분해효소와 정상세포에 바이러스의 침투를 막아주는 펙틴과 기타물질 또는 여기에 라이죠자임을 적당량 혼합하여 약액을 얻어 바이러스 침투에 의한 인체의 모든 질병을 치료하게 되는 피부염 약액의 제조방법이다.The present invention is obtained by mixing an appropriate amount of pectin and other substances that prevent the invasion of the virus into normal cells and a proper amount of lyozyme mixed with a protease that decomposes the cell nucleus protein damaged by the invasion of the virus to obtain a drug solution of the human body by virus invasion It is a method for preparing a dermatitis drug that will cure a disease.
Description
피부염 약액의 제조방법How to prepare dermatitis
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (1)
약액 100에 대하여 단백질 분해효소 0.01~15%와, 펙틴 5~6%, 기타 15~95% 혼합하거나, 여기에 라이죠자임 1~10%를 혼합시켜서 되는 피부염 약액의 제조방법.A method for producing a dermatitis drug solution by mixing 0.01-15% of protease, 5-6%, pectin 5-6%, and other 15-95% with respect to 100 drug solution, or 1-10% of lyozyme.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019940020091A1994-08-161994-08-16
How to prepare dermatitis
KR960006936A
(en)
Cosmetic or pharmaceutical composition of the oil-in-water emulsion type comprising a micronized biologically active agent and an appropriate emulsifying system and cosmetic treatment process
New formulation for inhalation; showing volumetric density, when poured, from 0.20 to 038 g / ml, comprising terbutaline sulfate, process for preparing the formulation and using it